Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE)
- PMID: 2025951
- PMCID: PMC1535404
- DOI: 10.1111/j.1365-2249.1991.tb08155.x
Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE)
Abstract
IgG anti-endothelial antibodies (AEA), as measured by ELISA or immunoblotting technique could be detected in serum samples of 56 out of 64 patients with SLE (88%) and mainly occurred in monomeric form. AEA were not cell specific, because the binding reactivity was absorbed partially by both fibroblasts and peripheral blood mononuclear cells. No correlation was found between the presence of AEA and anti-nuclear antibodies. Immunoblotting revealed reactivity of AEA against endothelial antigens ranging in size from 15 to 200 kD. AEA titres were significantly higher in patients with joint or skin abnormalities, compared with patients without these abnormalities. A significant correlation was found between nephritis in SLE and the presence of AEA reactivity against endothelial membrane antigens of 38, 41 and 150 kD. These data show that the pattern of AEA reactivity in serum of SLE patients is heterogeneous, and suggest that AEA against a limited number of antigens may be involved in the pathogenesis of nephritis in SLE.
Similar articles
-
Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.Clin Rheumatol. 2003 Oct;22(4-5):271-8. doi: 10.1007/s10067-003-0724-3. Clin Rheumatol. 2003. PMID: 14576989
-
Characterization of anti-endothelial antibodies in patients with rheumatoid arthritis complicated by vasculitis.Clin Exp Rheumatol. 1991 Nov-Dec;9(6):589-94. Clin Exp Rheumatol. 1991. PMID: 1764841
-
Antiendothelial cell antibodies in systemic lupus erythematosus: enhanced antibody binding to interleukin-1-stimulated endothelium.Int Arch Allergy Immunol. 1994;104(2):131-6. doi: 10.1159/000236720. Int Arch Allergy Immunol. 1994. PMID: 8199456
-
Antibodies against C1q in patients with systemic lupus erythematosus.Springer Semin Immunopathol. 2005 Nov;27(3):276-85. doi: 10.1007/s00281-005-0007-y. Epub 2005 Nov 11. Springer Semin Immunopathol. 2005. PMID: 16189648 Review.
-
Repeated intestinal ulcerations in a patient with systemic lupus erythematosus and high serum antiphospholipid antibody levels.South Med J. 1991 Apr;84(4):515-7. doi: 10.1097/00007611-199104000-00030. South Med J. 1991. PMID: 2014444 Review.
Cited by
-
Microvascular involvement in systemic sclerosis and systemic lupus erythematosus.Microcirculation. 2019 Apr;26(3):e12440. doi: 10.1111/micc.12440. Microcirculation. 2019. PMID: 29323451 Free PMC article. Review.
-
Anti-endothelial cell antibodies in systemic sclerosis.Clin Diagn Lab Immunol. 1999 Mar;6(2):156-60. doi: 10.1128/CDLI.6.2.156-160.1999. Clin Diagn Lab Immunol. 1999. PMID: 10066646 Free PMC article. Review. No abstract available.
-
Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies.Arthritis Res Ther. 2004;6(4):R366-72. doi: 10.1186/ar1198. Epub 2004 Jun 17. Arthritis Res Ther. 2004. PMID: 15225372 Free PMC article.
-
Atherosclerosis in Systemic Lupus Erythematosus.Curr Atheroscler Rep. 2023 Nov;25(11):819-827. doi: 10.1007/s11883-023-01149-4. Epub 2023 Sep 28. Curr Atheroscler Rep. 2023. PMID: 37768411 Review.
-
Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS).Clin Exp Immunol. 1995 Nov;102(2):368-72. doi: 10.1111/j.1365-2249.1995.tb03791.x. Clin Exp Immunol. 1995. PMID: 7586692 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical